SMAD4 and prostate cancer: Apc loss has also been shown to cooperate with hepsin overexpression or Smad4 loss to promote invasive prostate cancer, further indicating that invasive progression in Apc-deficient prostate cancer requires an additional genetic alteration [196,197].